🔍

Chemcrux Enterprises Ltd (540395)

📊 BSE: 540395 🏢 Specialty Chemicals 📢 Latest filing: 24 Aug 2026 📝 Analysis written: 13 Nov 2025

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Chemcrux Enterprises' revenue was ₹21.9 Cr (+33.0% year on year, -9.6% on the previous quarter), and net profit ₹0.5 Cr (+461.3% year on year); the operating margin was 12.3%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹21.9	+33.0%	-9.6%
Operating profit	₹2.7	+65.4%	-35.5%
Net profit	₹0.5	+461.3%	-72.7%
EPS (₹)	0.34	+466.7%	-72.8%
Operating margin	12.3%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Chemcrux Sets Sep 10 Record Date for ₹1/Share Final Dividend, Issues TDS Guidelines

🟡 NEUTRAL ⭐ 3/10

DIVIDEND 📅 24 Aug 2026, 05:44 PM

Chemcrux Enterprises has issued a formal communication to shareholders regarding Tax Deducted at Source (TDS) on the recommended final dividend of ₹1 per equity share (face value ₹10) for FY 2025-26. The record date to determine shareholder eligibility is fixed for September 10, 2026, subject to approval at the 30th AGM scheduled for September 17, 2026. The dividend is slated for payment electronically on or before October 17, 2026. The document details applicable withholding tax rates (10% for residents, 20% for non-residents) and instructions for submitting exemption forms.

Final dividend recommended at ₹1 per equity share of face value ₹10 for FY 2025-26
Record date set for September 10, 2026, with AGM scheduled for September 17, 2026
Dividend payment to eligible shareholders on or before October 17, 2026
Standard TDS rate of 10% applies to resident individuals if total dividend exceeds ₹10,000
Non-resident shareholders subject to 20% TDS plus applicable surcharge/cess or relevant DTAA rates

💡 Shareholders seeking lower or nil tax deduction should submit the required tax exemption forms (Form 121/treaty declarations) and ensure PAN-Aadhaar linking before the record date of September 10, 2026.

Chemcrux Enterprises issues TDS circular for Re 1/share FY26 final dividend; Record date Sep 10

🟡 NEUTRAL ⭐ 3/10

DIVIDEND 📅 24 Aug 2026, 05:27 PM

Chemcrux Enterprises has released an informational circular for shareholders regarding Tax Deducted at Source (TDS) on its recommended final dividend of Re. 1 per equity share (face value Rs. 10) for FY 2025-26. The dividend is subject to approval at the 30th Annual General Meeting on September 17, 2026. The record date for determining eligible shareholders is September 10, 2026, with payment to be completed on or before October 17, 2026. Standard TDS is 10% for resident individuals with no deduction applicable on payouts up to Rs. 10,000.

Recommended final dividend of Re. 1/- per equity share of face value Rs. 10/- for FY 2025-26
Record date fixed as 10th September 2026 for eligible shareholders
30th Annual General Meeting scheduled for 17th September 2026
Payment to be disbursed electronically on or before 17th October 2026
Standard TDS rate of 10% for resident shareholders (nil withholding if total dividend is <= Rs. 10,000)

💡 Shareholders seeking lower or nil TDS must submit relevant tax exemption forms (Form 121 / 15G / 15H / TRC) and verify PAN-Aadhaar linking with depositories ahead of the record date.

Chemcrux Enterprises: Two Independent Directors Complete 10-Year Tenure and Step Down

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 24 Aug 2026, 05:18 PM

Chemcrux Enterprises announced the cessation of two Independent Directors, Mr. Bhanubhai Patel and Mr. Shailesh Patel, effective end of day August 23, 2026. Both directors completed their maximum statutory tenure of two consecutive terms of five years each (total 10 years) under the Companies Act, 2013. The company confirmed there are no other material reasons for their cessation. This is a routine statutory governance change with no operational or financial disruption.

Mr. Bhanubhai Patel (DIN: 00727280) ceased as Independent Director effective end of day August 23, 2026
Mr. Shailesh Patel (DIN: 02826895) ceased as Independent Director effective end of day August 23, 2026
Both directors completed 2 consecutive 5-year terms (10 years total) on August 23, 2026
No other material reasons cited for their cessation

💡 Track subsequent filings for the appointment of new independent directors to ensure statutory board composition and committee compliance are maintained.

Chemcrux Enterprises Sets Record Date on Sep 10, 2026 for 30th AGM & Dividend

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 21 Aug 2026, 05:09 PM

Chemcrux Enterprises Ltd has scheduled its 30th Annual General Meeting (AGM) for September 17, 2026, via Video Conference. The company has fixed September 10, 2026, as the record date and cut-off date to determine shareholder eligibility for e-voting and any dividend declared at the AGM. The register of members will remain closed from September 11 to September 17, 2026. Remote e-voting is scheduled from September 14 to September 16, 2026.

30th AGM scheduled for 17th September 2026 at 2:00 PM IST via VC/OAVM
Record date set for 10th September 2026 for dividend eligibility (if declared at AGM)
Cut-off date for e-voting eligibility fixed as 10th September 2026
Book closure period runs from 11th September 2026 to 17th September 2026 (both days inclusive)
Remote e-voting window open from 14th September 2026 (9:00 AM) to 16th September 2026 (5:00 PM)

💡 Shareholders seeking eligibility for voting or dividend entitlement must hold shares as of the record date on September 10, 2026.

Chemcrux Enterprises Sets September 10, 2026 as Record Date for Final Dividend

🟡 NEUTRAL ⭐ 3/10

DIVIDEND 📅 21 Aug 2026, 05:05 PM

Chemcrux Enterprises Ltd has fixed September 10, 2026, as the record date to determine shareholder eligibility for the FY26 final dividend. The dividend will be subject to approval at the company's 30th Annual General Meeting (AGM) scheduled for September 17, 2026. If approved, the dividend will be disbursed within the statutory 30-day timeline on or before October 17, 2026. The company reported FY26 net profit of ₹3.73 Cr on revenue of ₹80.65 Cr.

Record date fixed as 10th September 2026 for final dividend entitlement
30th Annual General Meeting (AGM) scheduled for 17th September 2026
Dividend payment to be completed on or before 17th October 2026 (within 30 days of AGM)

💡 Track the 30th AGM proceedings on September 17, 2026, for formal shareholder approval of the FY26 final dividend and upcoming Q2 FY27 performance updates.

Chemcrux Enterprises 30th AGM on Sep 17, 2026; Proposes ₹1/Share Final Dividend

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 21 Aug 2026, 04:28 PM

Chemcrux Enterprises has issued the notice for its 30th Annual General Meeting scheduled for September 17, 2026. The company is seeking shareholder approval for a final dividend of ₹1.00 per share (10%) on 1,48,08,840 equity shares for FY25-26, with an entitlement record date of September 10, 2026. The agenda also includes approving maximum remuneration caps of ₹3.00 crore per annum each for Executive Chairman Girishkumar Shah and Managing Director Sanjay Marathe for 2027-2028, along with appointing an Independent Director.

30th Annual General Meeting scheduled for September 17, 2026 via VC/OAVM.
Final dividend of ₹1.00 per share (10%) proposed on 1,48,08,840 equity shares, totaling ~₹1.48 crore.
Shareholder record date for dividend eligibility set as September 10, 2026.
Special resolutions proposed for managerial remuneration ceiling of up to ₹3.00 crore per annum each for Executive Chairman and Managing Director.
Appointment of Ms. Zarna Pankaj Thakar as Non-Executive Independent Director for a 1-year term.

💡 Track voting outcomes post-AGM on September 17, 2026, and note the September 10, 2026 record date for dividend entitlement.

Chemcrux Enterprises Submits FY26 Annual Report; 30th AGM on Sept 17, Proposes ₹1 Dividend

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 21 Aug 2026, 04:06 PM

Chemcrux Enterprises Limited has submitted its Annual Report for FY 2025-26 and scheduled its 30th Annual General Meeting for September 17, 2026. The Board has recommended a final dividend of ₹1.00 per equity share (10%) on 1,48,08,840 shares for eligible members as of September 10, 2026, totaling approximately ₹1.48 crore. In the financial disclosures, Capital Work-in-Progress stood at ₹4.07 crore as of March 31, 2026, up from ₹1.60 crore in FY25. The company also seeks shareholder approval for executive remuneration up to ₹3 crore per annum for the Executive Chairman.

30th Annual General Meeting scheduled for Thursday, 17th September 2026 via Video Conferencing
Final dividend proposed at ₹1.00 (10%) per share on 1,48,08,840 equity shares
Record date for dividend entitlement set for 10th September 2026
Capital Work-in-Progress (CWIP) increased to ₹406.73 Lakhs as of March 31, 2026 (vs ₹159.83 Lakhs in FY25)
Proposed remuneration cap of up to ₹3 Crores per annum for Whole Time Director & Executive Chairman

💡 Track the AGM voting outcomes on September 17, 2026, particularly regarding director remuneration and dividend declaration, as well as the record date of September 10, 2026.

Resignation of Non-Executive Director Sidhdhi Girishkumar Shah Effective August 4, 2026

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 04 Aug 2026, 07:45 PM

Mrs. Sidhdhi Girishkumar Shah has resigned from her position as a Non-Executive, Non-Independent Director of Chemcrux Enterprises Ltd, effective August 4, 2026. She cited 'pre-occupation' as the reason for her departure and will also step down as the Chairperson of the Stakeholders Relationship Committee. The company, a micro-cap specialty chemicals player with a market capitalization of Rs 143 Cr, stated there are no other material reasons for the resignation. This is a routine administrative change in the board's composition.

Resignation of Mrs. Sidhdhi Girishkumar Shah effective from August 4, 2026
Stepping down as Chairperson of the Stakeholders Relationship Committee
Reason for resignation cited as pre-occupation with no other material reasons
Company maintains a high promoter holding of 72.92% as of June 2026

💡 Monitor the company's next board meeting update for the appointment of a new Chairperson for the Stakeholders Relationship Committee to ensure governance continuity.

Chemcrux Enterprises Appoints Ms. Zarna Pankaj Thakar as Independent Director for 1-Year Term

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 04 Aug 2026, 07:43 PM

Chemcrux Enterprises has appointed Ms. Zarna Pankaj Thakar as an Additional Director (Non-Executive, Independent) effective August 4, 2026. Ms. Thakar is a Cost and Management Accountant (CMA) with over 10 years of experience in financial oversight, strategic cost management, and internal controls. The appointment is for a one-year term ending August 3, 2027, and is subject to shareholder regularization at the upcoming Annual General Meeting (AGM). This move adds specialized financial and cost-governance expertise to the board of this Rs 143 Cr market cap specialty chemicals firm.

Appointment of Ms. Zarna Pankaj Thakar as Independent Director effective August 4, 2026
Appointee brings over 10 years of experience in cost management and financial oversight
Initial term is set for 1 year, concluding on August 3, 2027
Ms. Thakar holds nil shares in the company as of the appointment date

💡 Monitor the upcoming Annual General Meeting (AGM) for the formal regularization of this appointment by shareholders.

Chemcrux Q1 PAT Jumps 466% YoY to ₹0.51 Cr; Revenue Up 33% YoY

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 04 Aug 2026, 07:35 PM

Chemcrux Enterprises reported a strong year-on-year recovery for Q1 FY27, with consolidated revenue rising 33% to ₹21.94 Cr from ₹16.50 Cr. Consolidated Net Profit surged to ₹0.51 Cr compared to a low base of ₹0.09 Cr in the same quarter last year. However, performance weakened sequentially (QoQ), with revenue down 9.6% and PAT dropping 72% from ₹1.85 Cr in Q4 FY26. A notable gap exists between standalone PAT (₹1.37 Cr) and consolidated PAT (₹0.51 Cr), indicating losses in its wholly-owned subsidiary, Kalichem Private Limited.

Consolidated Revenue from operations grew 33% YoY to ₹21.94 Cr.
Consolidated PAT increased significantly to ₹0.51 Cr from ₹0.09 Cr in Q1 FY26.
Standalone PAT of ₹1.37 Cr was substantially higher than consolidated PAT, implying a ₹0.86 Cr loss in the subsidiary.
Granted 1,07,700 Employee Stock Options (ESOPs) on May 15, 2026, at an exercise price of ₹10.
Finance costs reduced to ₹0.64 Cr from ₹0.86 Cr on a YoY basis.

💡 Investors should monitor the turnaround progress of the subsidiary Kalichem Private Limited, as its losses are currently dragging down consolidated profitability. Watch for the stabilization of operating margins, which were impacted by a sequential rise in raw material costs relative to revenue.

Chemcrux Enterprises Approves Q1 FY27 Results; 30th AGM Set for Sept 17, 2026

🟡 NEUTRAL ⭐ 4/10

EARNINGS 📅 04 Aug 2026, 07:31 PM

Chemcrux Enterprises approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, during a board meeting on August 4, 2026. The company also scheduled its 30th Annual General Meeting (AGM) for September 17, 2026, to be held via video conferencing. This follows a fiscal year (FY26) where the company reported a revenue of Rs 80.65 Cr and a net profit of Rs 3.73 Cr. The board meeting lasted approximately 2 hours and 20 minutes.

Board meeting held on August 4, 2026, from 05:00 P.M. to 07:20 P.M.
30th Annual General Meeting (AGM) scheduled for September 17, 2026, at 02:00 P.M.
Approval of Unaudited Standalone and Consolidated Financial Results for Q1 FY27.
Company reported TTM revenue of Rs 81 Cr and TTM PAT of Rs 4 Cr as per latest context.

💡 Investors should examine the detailed Q1 FY27 financial tables to assess if the company is maintaining the sequential growth seen in Q4 FY26 (Revenue: Rs 24.28 Cr).

Board Meeting Scheduled for August 4, 2026, to Approve Q1 FY27 Financial Results

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 28 Jul 2026, 06:19 PM

Chemcrux Enterprises has announced that its Board of Directors will meet on August 4, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. This follows a fiscal year where quarterly revenue grew steadily from Rs 16.5 crore in June 2025 to Rs 24.28 crore in March 2026. The company currently operates with a TTM revenue of Rs 81 crore and a market capitalization of Rs 133 crore. The trading window for insiders remains closed until 48 hours after the results are declared.

Board meeting scheduled for August 4, 2026, at 05:00 P.M. to approve Q1 FY27 results.
Trading window for designated persons closed from July 1, 2026, until 48 hours post-announcement.
Company reported a TTM revenue of Rs 81 crore and a TTM PAT of Rs 4 crore.
Promoter holding remains stable at 72.92% as of June 2026.
The meeting will be preceded by an Audit Committee meeting on the same day.

💡 Investors should monitor the results on August 4 to evaluate if the company can sustain the sequential revenue growth and margin improvement (17.2% OPM in Mar 2026) seen in recent quarters.

Chemcrux Enterprises incorporates ₹1 Lakh CSR subsidiary 'Chemcrux Foundation'

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 17 Jul 2026, 03:35 PM

Chemcrux Enterprises has incorporated a wholly-owned subsidiary (WOS) named Chemcrux Foundation on July 17, 2026. The new entity is a Section 8 (non-profit) company with a paid-up capital of ₹1,00,000. Its primary purpose is to manage and fulfill the company's Corporate Social Responsibility (CSR) obligations. This is a routine administrative development with no impact on the company's commercial operations or revenue-generating capacity.

Incorporation of Chemcrux Foundation as a 100% wholly-owned subsidiary on July 17, 2026.
Initial paid-up share capital of ₹1,00,000 consisting of 10,000 equity shares.
The entity is registered as a Section 8 Company under the Companies Act, 2013, for non-profit activities.
The primary objective is to fulfill CSR obligations including social welfare and environmental protection.

💡 No action is required as this is a procedural filing for CSR compliance; investors should focus on the core chemical business performance in upcoming quarterly results.

View All 540395 Announcements on Live Market Tracking →